norethindrone has been researched along with alprazolam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alberti, I; Carrara, DN; Grenier, A; Kraus, H | 1 |
| Endo, T; Kawamura, S; Maruta, M; Sakai, A | 1 |
1 review(s) available for norethindrone and alprazolam
| Article | Year |
|---|---|
Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
Topics: Administration, Cutaneous; Alprazolam; Animals; Anti-Anxiety Agents; Drug Delivery Systems; Estradiol; Female; Gels; Humans; Hypogonadism; Male; Mandelic Acids; Norethindrone; Parasympatholytics; Progesterone Congeners; Testosterone; Urinary Bladder, Neurogenic | 2005 |
2 other study(ies) available for norethindrone and alprazolam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Atypical depression as a premonitory symptom of migraine managed by an oral contraceptive.
Topics: Adult; Alprazolam; Borderline Personality Disorder; Calcium Channel Blockers; Contraceptives, Oral, Combined; Depressive Disorder, Major; Drug Combinations; Drug Therapy, Combination; Female; Humans; Mestranol; Migraine with Aura; Norethindrone; Piperazines; Suicide, Attempted; Valproic Acid | 2008 |